What is Felbatol ?

Felbamate is an anticonvulsant medication primarily used in the management of severe epilepsy, particularly in cases like Lennox-Gastaut syndrome that are resistant to other treatments. It functions by modulating neurotransmitter activity in the brain to prevent the occurrence of seizures. Due to potential serious side effects such as aplastic anemia and liver failure, its use is typically reserved for patients who have not responded adequately to other anticonvulsants.

• Nausea
• Vomiting
• Insomnia
• Dizziness
• Fatigue
• Loss of appetite
• Changes in taste
• Vision changes
• Headache
• Gastrointestinal discomfort

• Felbamate has been associated with a risk of aplastic anemia; monitor blood counts regularly.
• Risk of acute liver failure; liver function tests should be conducted periodically.
• Not recommended in patients with a history of blood dyscrasias.
• Use with caution in patients with existing liver impairment.
• Monitor for signs of hypersensitivity or allergic reactions.
• Avoid abrupt discontinuation to prevent potential withdrawal seizures.
• Potential interactions with other antiepileptic drugs; adjust dosages as necessary.
• Safety during pregnancy is not established; use only if clearly needed.
• May impair ability to drive or operate machinery.
• Keep out of reach of children.